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Abstract
Background: Externalization of phosphatidylserine (EPS) occurs in apoptotic-like spermatozoa
and could be used to remove them from sperm preparations to enhance sperm quality for assisted
medical procreation. We first characterized EPS in sperms from infertile patients in terms of
frequency of EPS spermatozoa as well as localization of phosphatidylserine (PS) on spermatozoa.
Subsequently, we determined the impact of depleting EPS spermatozoa on sperm quality.
Methods: EPS were visualized by fluorescently-labeled annexin V binding assay. Double staining
with annexin V and Hoechst differentiates apoptotic from necrotic spermatozoa. We used
magnetic-activated cell sorting using annexin V-conjugated microbeads (MACS-ANMB) technique
to remove EPS spermatozoa from sperm prepared by density gradient centrifugation (DGC). The
impact of this technique on sperm quality was evaluated by measuring progressive motility, viability,
and the integrity of the mitochondrial membrane potential (MMP) by Rhodamine 123.
Results: Mean percentages of EPS spermatozoa were 14% in DGC sperm. Four subpopulations of
spermatozoa were identified: 70% alive, 3% early apoptotic, 16% necrotic and 11% late apoptotic
or necrotic. PS were localized on head and/or midpiece or on the whole spermatozoa. MACS
efficiently eliminates EPS spermatozoa. MACS combined with DGC allows a mean reduction of 70%
in EPS and of 60% in MMP-disrupted spermatozoa with a mean increase of 50% in sperm survival
at 24 h.
Conclusion: Human ejaculates contain EPS spermatozoa which can mostly be eliminated by DGC
plus MACS resulting in improved sperm long term viability, motility and MMP integrity. EPS may be
used as an indicator of sperm quality and removal of EPS spermatozoa may enhance fertility
potential in assisted medical procreation.
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Background
Human sperm quality is defined by the classical parame-
ters, concentration, motility and morphology, according
to standard World Health Organisation diagnostic semen
analysis [1]. Nevertheless, hidden anomalies affecting
spermatozoa membranes such as externalization of the
phosphatidylserine (EPS), or spermatozoa organelles
such as the disruption of mitochondrial membrane
potential (MMP), caspases activation and/or DNA frag-
mentation, are common somatic features of apoptosis.
Such features are not routinely detected in ejaculated sper-
matozoa but they have been proven to have a negative
impact on assisted medical procreation (AMP) outcome
[2-8]. Indeed, successful assisted reproduction is mainly
dependent on the quality of the sperm plasma membrane,
requiring normal integrity and function to provide motil-
ity, acrosome reaction, and fertilization [9]. Spermatozoa
with impaired membrane integrity occur more frequently
in infertile men, partly explaining suboptimal results in
AMP. However, striking modifications of sperm plasma
membrane occur physiologically in ejaculated sperm.
During capacitation, there is an AC/cAMP/PKA-depend-
ent lipid remodelling of the sperm plasma membrane due
to phospholipids translocation that lead to externaliza-
tion of phosphatidylserine (PS) and phosphatidyleth-
anolamine, and to an albumin mediated efflux of
cholesterol resulting in an increase in membrane fluidity
[10-16].
Apoptosis plays a critical role in many normal biological
processes such as embryogenesis and tissue homeostasis,
as well as in pathological states and diseases. Apoptosis
causes disruption of membrane, phospholipid asymmetry
and translocation of PS, a signal for specific recognition
and removal of apoptotic cells by phagocytosis [17-20].
Annexin V, an anticoagulant protein of 35.8 kDa, binds
outwardly exposed PS with high affinity in a calcium-
dependent manner [21]. Thus, the combined use of
annexin V and of a supravital fluorescent dye, such as
Hoechst 33258, allows the simultaneous detection of
apoptotic and necrotic cells [22]. Currently, it is known
that germinal cells apoptosis is an underlying mechanism
of normal spermatogenesis and an altered apoptotic proc-
ess has been found to be closely associated with abnormal
spermatozoa in semen and thus with male infertility [23-
26]. Indeed, Maeda et al. [27] inhibited sperm production
in mice by annexin V microinjection into seminiferous
tubules, showing that the phagocytic clearance of apop-
totic spermatogenic cells by Sertoli cells is PS-mediated
and required for a normal production of sperm. In con-
trast, apoptosis in ejaculated sperm is less well understood
and remains controversial [28]. Few reports applied the
detection of EPS, by annexin V-labeling, for the evaluation
of cryopreservation techniques on ram [29,30], boar
[31,32], bull [33-35], and human [36-43] spermatozoa.
Other human sperm studies attempted to relate EPS, DNA
fragmentation and/or apoptotic proteins with sperm
quality parameters [6,7,15,44-56]. It comes out from the
literature that EPS on ejaculated mature spermatozoa is
either the result of a plasma membrane modification
because of capacitation and/or acrosome reaction
[11,15,54] or the sign of an early apoptotic phenotype
[45,57]. Sakkas et al. [2,58] proposed that apoptosis in
ejaculated sperm is the result of a spermatogenetic failure,
thus an abortive apoptotic process that started before ejac-
ulation [59]. It has also been described that inflammation
[60-62] and bacteria can induce EPS in human spermato-
zoa [63]. Nevertheless, the link between EPS and sperm
apoptosis is still controversial, although it is accepted that
annexin V binding to spermatozoa characterizes modified
sperm plasma membrane. Interesting results on EPS in
relationship with infertility problems in AMP are those of
collaborators at the Reproductive Research Center of the
Cleveland Clinic (USA), and at the Department of Derma-
tology and Andrology of Leipzig University (Germany)
[39,51,64-70] who adapted the technique of magnetic-
activated cell sorting using annexin V-conjugated
microbeads (MACS-ANMB) to sperm preparations in
order to evaluate the impact of EPS on sperm parameters
and fertility potential.
In the present study, we have characterized EPS on sper-
matozoa after DGC sperm preparation and tested its
impact on the quality of sperm prepared for AMP, an
essential element for successful fertilization and reproduc-
tive success. EPS is the main sperm surface apoptotic
marker but its role in ejaculated sperm remains ambigu-
ous. We have investigated the effects of removal of EPS-
positive spermatozoa on the motility and MMP integrity
of prepared spermatozoa in patients consulting for infer-
tility. To this end, we have depleted sperm preparations of
EPS spermatozoa by affinity to annexin V. The patient
population studied, consulting for infertility, presented
subobptimal semen characteristics and could benefit from
removal of EPS sperm, using ANMB-MACS from sperm
preparations. This study has tested the feasibility of such
purification given the limited amounts of viable sperma-
tozoa available in the ejaculates of these patients. These
data allow to draw guidelines for the clinical application
of this purification in low concentration and/or bad qual-
ity sperm.
Firstly, we determined the proportion of EPS-positive
spermatozoa in noncapacitated and capacitated sperma-
tozoa, and secondly we precisely localized PS on sperma-
tozoa among sperms of patients consulting our infertility
unit. Further, we compared raw sperm with two sperm
preparations, DGC and DGC combined with MACS-
ANMB, for percentages of EPS-positive spermatozoa, of
viability, of progressive motility and of spermatozoa with
disrupted MMP. Collectively, these data allowed to evalu-
ate in details the quality of sperm preparations after elim-Reproductive Biology and Endocrinology 2009, 7:1 http://www.rbej.com/content/7/1/1
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ination of EPS-positive spermatozoa by MACS-ANMB in
our population of infertile patients in AMP conditions.
Methods
Sperm preparation
This study was approved by the ethic committee of the
Gynaecology and Obstetrics Department, Geneva Univer-
sity Hospital, Switzerland.
Human sperm, collected following an abstinence of 3–5
days, were obtained from men attending the Unit of
Reproductive Medicine (Geneva University Hospital,
Switzerland), after signing a written informed consent.
Semen (standard) parameters were thus obtained. After
liquefaction, ejaculated sperm were prepared using PureS-
perm® (NidaCon laboratories AB, Gothenburg, Sweden)
or SpermFilter® (Cryos, Denmark) DGC (90–45%). The
pellet of the 90% fraction was washed in BM1 medium
(Synthetic medium for human in vitro cell culture, NMS
BIO MEDICAL AG, Suisse), centrifuged for 10 min at 300
g and resuspended in BM1 medium and placed in an incu-
bator at 37°C in a humidified atmosphere of 6% CO2,
before applying on MACS-ANMB according to the experi-
mental design. Selection of sperm by DGC was conducted
in BM1, a capacitating medium. For capacitation experi-
ments, sperm suspensions were further incubated for 3–5
h at 37°C in a humidified atmosphere of 6% CO2. For
sperm survival analysis, sperm suspensions in BM1
medium were maintained in the incubator at 37°C in a
humidified atmosphere of 6% CO2 for 24 h.
Sperm parameters were determined in accordance with
the World Health Organization guidelines [1]. Sperm
concentration was assessed using a Makler®  Chamber.
Sperm motility was assessed with 10 μl of suspension
between slide and cover-slide. Sperm viability and mor-
phology were assessed using eosin-nigrosin and Papani-
colaou staining, respectively [1].
Experimental design
Sperm count (concentration in million spermatozoa per
ml), progressive motility, EPS-positive spermatozoa and
MMP-disrupted spermatozoa were evaluated in liquefied
sperm (raw samples) after sperm preparations by DGC
alone or by combining DGC with MACS-ANMB. We also
evaluated sperm survival 24 h following DGC combined
with MACS. We determined the sperm recovery rate after
MACS preparation. We also applied MACS to low amount
of spermatozoa and/or bad quality sperm in order to
define the limit of application of this technique.
Detection and evaluation of EPS-positive spermatozoa in 
DGC sperm preparation
Prepared spermatozoa were adjusted at a concentration of
0.5–1 million/ml and washed with 1× Binding Buffer (BD
Biosciences Pharmingen, San Diego, CA). Spermatozoa
were then resuspended in 100 μl 1× Binding Buffer con-
taining 5–10 μl fluorescein isothiocyanate (FITC)-labeled
annexin V, according to the manufacturer's instructions
(BD Biosciences Pharmingen), and 0.5 μg/ml Hoechst
33258 (Sigma-Aldrich, Switzerland) and incubated for 15
min at room temperature in the dark. Spermatozoa sus-
pensions were washed with Binding Buffer and centri-
fuged at 400 g. Supernatants were removed and pellets
resuspended in 10–15 μl of Binding Buffer and deposited
on glass slides. Two types of preparations were done, with
or without mounting media for fluorescence, Vectashield
(Vector Laboratories, Burlingame, CA), before covering
the slide with a coverslip. The first preparation used for
the localization of annexin V staining on spermatozoa
and the second one for the double labeling with annexin
V-FITC and vital dye Hoechst allowing the distinction
between spermatozoa with or without EPS, and between
intact and dead spermatozoa, respectively. Spermatozoa
were analysed under a Nikon fluorescent microscope
using a dual filter set for FITC and Hoechst. The specificity
of binding of annexin V-FITC to human spermatozoa was
demonstrated in control experiments by preincubating
spermatozoa with excess purified recombinant annexin V
(BD Bioscience Pharmingen) before performing the test
or by performing the assay in Binding Buffer in the
absence of calcium. Both control conditions prevented
the binding of annexin V-FITC to PS-positive spermato-
zoa. The sensitivity of the assay was tested by using
decreasing amounts of spermatozoa and of annexin-V-
FITC concentrations.
Depletion of EPS-positive spermatozoa by magnetic-
activated cell sorting (MACS) method using annexin V 
magnetic beads (ANMB)
The sperm suspensions were divided into two fractions by
passage through a magnetic field (miniMACS, Miltenyi
Biotec GmbH, Germany) based on the binding of para-
magnetic annexin V-microbeads to PS present on the sur-
face of spermatozoa [39,50,71]. Briefly, DGC-prepared
spermatozoa were incubated with annexin V-conjugated
microbeads (Miltenyi Biotec GmbH) for 15 min at room
temperature. About 100 μl of annexin V microbeads sus-
pension were used for each 10 million spermatozoa. The
spermatozoa/microbeads suspension was loaded on a
separation MS column containing iron balls, which was
fitted in a miniMACS separator (magnet) attached to a
multistand (Miltenyi Biotec GmbH). The fraction with
intact membranes that passed through the column was
labeled as MACS-ANMB-negative fraction, depleted in PS,
whereas the fraction composed of apoptotic or deterio-
rated PS-positive membranes spermatozoa was retained
in the separation column and labeled as MACS-ANMB-
positive fraction. After the column was removed from theReproductive Biology and Endocrinology 2009, 7:1 http://www.rbej.com/content/7/1/1
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magnetic field, the retained fraction was eluted using
annexin V-binding buffer (Miltenyi BiotecGmbH).
Evaluation of EPS
Raw semen samples were washed in BM1 medium before
annexin V-FITC staining. Samples of 0.5 to 1 million sper-
matozoa from either washed raw spermatozoa, DGC or
DGC combined with MACS preparations were washed
with Binding Buffer, centrifuged at 400 g for 5 min and
resuspended in 100 μl Binding Buffer containing 5 μg/ml
annexin V-FITC (BD Bioscience Pharmingen) for 15 min
at room temperature in the dark. At the end of the labe-
ling, 500 μl Binding Buffer were added to the samples and
centrifuged at 400 g for 5 min. 5–10 μl of the antifading
Vectashield were added to 10–15 μl of the pellets and
deposited on glass slides and rapidly observed under a
Nikon fluorescence microscope with a 100-fold objective.
At least 200 spermatozoa per slide were examined.
Evaluation of Mitochondrial Membrane Potential (MMP)
Rhodamine 123 (Rh123) is a cell-permeant, cationic, flu-
orescent dye that is readily sequestered by active mito-
chondria without inducing cytotoxic effects. Uptake and
equilibration of Rh123 is rapid, within a few minutes.
Viewed through a fluorescein longpass optical filter, fluo-
rescence of mitochondria stained by Rh123 appears yel-
low-green or red with a Rhodamine filter. The staining
procedure was performed according to Auger et al. [72].
Briefly, samples of 0.5 to 1 million spermatozoa prepared
by either DGC or DGC combined with MACS were incu-
bated in BM1 containing 10 μg/ml Rh123 (Molecular
Probes, Leiden, The Nederlands) for 10 min at room tem-
perature in the dark; samples were then pelleted by cen-
trifugation at 400 g, resuspended in BM1 and incubated
for 30 min in dye-free BM1 to eliminate the dye not spe-
cifically bound to mitochondria. Samples were then pel-
leted and 15–20 μl were deposited on glass slides and
rapidly observed under a Nikon fluorescence microscope
with a 100-fold objective. At least 200 spermatozoa per
slide were examined.
Statistical analysis
Results were expressed as mean ± SEM. To compare
parameters between raw, DGC and DGC combined with
MACS paired or non-paired Student's t-test were used.
Potential correlations between sperm annexin V-positivity
and MMP integrity and between the amount of spermato-
zoa loaded on MACS and MACS recovery rate were evalu-
ated by determining Pearson's correlation coefficients and
linear regression analysis. P values < 0.05 were considered
statistically significant. Statistical analysis were performed
using Excel on a HP computer.
Results
Identification and quantification of EPS-positive 
spermatozoa in noncapacitated and capacitated human 
spermatozoa
During sperm capacitation and/or acrosome reaction as
well as early in apoptosis there is a loss of the asymmetry
of the plasma membrane phospholipid PS. Annexin V
binding to spermatozoa indicates the translocation of PS
(EPS) from the inner to the outer layer of the plasma
membrane. Using annexin V-FITC binding assay coupled
to the vital dye Hoechst 33258, we identified four sub-
populations of human DGC-prepared noncapacitated
spermatozoa (Table 1). with an average mean of: 1) 70%
live intact spermatozoa with no EPS (no fluorescence),
namely annexin V-negative and Hoechst-negative (A-/H-),
2) 3% live spermatozoa with EPS (green), namely A+/H-,
corresponding to early apoptotic spermatozoa, 3) 16%
dead spermatozoa with no EPS but positive for Hoechst
(blue), namely A-/H+, and 4) 11% spermatozoa with EPS
and positive for Hoechst (blue and green), namely A+/H+,
corresponding to late apoptotic or necrotic spermatozoa
Nevertheless, there is a great variability among sperm var-
ying from 0 to 15% for the A+/H- subpopulation, 1 to
34% for the A+/H+ subpopulation and from 2 to 38% for
total annexin V-positive spermatozoa. We found an aver-
age of 14% (11% A+/H+ and 3% A+/H-, annexin V-posi-
tivity) EPS-positive spermatozoa following DGC
preparation of sperm (Table 1). Similar proportions of
EPS-positive spermatozoa were found using the mouse
Table 1: Identification and quantification of EPS-positive spermatozoa by Annexin V-FITC labeling in DGC-prepared sperm.
Subpopulations of spermatozoa DGC-prepared sperm
Noncapacitated sperm (n = 17)
DGC-prepared sperm
Capacitated sperm (n = 17)
Annexin V-/Hoechst - (%A-/H-) 70.2 ± 5.8 (18–96) 66.2 ± 5.3 (25–91)S
Annexin V-/Hoechst + (%A-/H+) 15.7 ± 4.1 (1–52) 13.8 ± 3.6 (2–52) NS
Annexin V+/Hoechst - (%A+/H-) 2.9 ± 0.8 (0–15) 3.6 ± 0.6 (1–8) NS
Annexin V+/Hoechst + (%A+/H+) 11.2 ± 2.4 (1–34) 16.4 ± 2.7 (4–39)S
Total Annexin V + (%A+)
(%A+/H-)+(%A+/H+)
14.2 ± 2.7 (2–38) 20.1 ± 2.8 (5–41) S
Apoptotic index (A+/H-)/total (H-) 4.5 ± 1.2 (0–22) 5.7 ± 0.9 (1–11) NS
values are mean percentages ± SEM (minimum-maximum values).
NS = statistically not significant compared to noncapacitated sperm (paired t-test).
S = statistically significant compared to noncapacitated sperm with p < 0.05 (paired t-test).Reproductive Biology and Endocrinology 2009, 7:1 http://www.rbej.com/content/7/1/1
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monoclonal IgG anti-Phosphatidylserine, clone 1H6
(Upstate, NY, USA) coupled to an anti mouse IgG-FITC
(Sigma-Aldrich) (data not shown).
Our results showed that there is a moderate increase in the
percentage of total annexin V-positive (A+/H- and A+/H+)
spermatozoa, following incubation in capacitating condi-
tions. This increase concerns only the A+/H+ subpopula-
tion since there is not a statistically significant increase in
the early apoptotic annexin V-positive and Hoechst-nega-
tive (A+/H-) subpopulation of spermatozoa nor in the
apoptotic index, (A+/H-)/total H-, following capacitation
(Tables 1 and 2). The increase in EPS-positivity during
capacitation involves 47% and 18% (fold increase supe-
rior to 1.5 and 2, respectively) of the sperm analysed with
a mean percentage increase from 14 to 20% (Table 1).
Localization of PS on human spermatozoa
PS was localized on head alone, head plus midpiece, mid-
piece alone, tail or on the entire spermatozoon (Figure 1
and Table 2). Among the annexin V-positive spermatozoa
population (13%), about 15% are labeled on head, 8%
on midpiece and 12% on head and midpiece (Table 2).
Head PS labeling can concern the apical, basal, equatorial
region or entire head, and for midpiece PS labeling, the
upper, lower region or whole midpiece. PS localization
thus vary among spermatozoa involving either the head
and/or midpiece region or the entire spermatozoa. A
slight significative increase in annexin V-positivity in the
categories head and head plus midpiece was observed
under capacitation conditions (Table 2).
Study design and sperm samples evaluation
We thus studied 44 sperms of patients consulting our
AMP laboratory of the Unit of Reproductive Medicine at
our institution. Our study focused on the evaluation of
the quality of spermatozoa prepared by MACS-ANMB.
Sperm parameters such as concentration and motility,
and the apoptotic markers, EPS and MMP, were deter-
mined on raw sperm samples, and on sperm samples fol-
lowing DGC or DGC combined with MACS-ANMB
preparations (Figure 2). Two fractions were obtained fol-
lowing MACS-ANMB, the non apoptotic, annexin V-nega-
tive and the apoptotic, annexin V-positive (Figure 2). Raw
sperm parameters are presented in Table 3. Insufficient
amount and/or bad quality of some sperm samples led us
to partial analysis of our parameters. We thus formed sub-
groups of sperm according to the parameters analysed, i.e.
EPS, MMP, progressive motility, and survival at 24 h
(Tables 4 and 5). All classical sperm parameters, i.e. vol-
ume, concentration, total count, motility and morphol-
ogy are shown in Table 3 and were not statistically
different between these subgroups. In raw sperm, EPS-
positivity and MMP integrity were inversely correlated (R
= -0.37).
DGC combined with MACS-ANMB was efficient in 
reducing the sperm population in EPS-positive 
spermatozoa
The mean percentage of EPS-positive spermatozoa in raw
sperm samples was 22% (n = 21), this value fall to 13%
following DGC preparation and to 7% after DGC com-
bined with MACS-ANMB (Table 4). DGC sperm prepara-
tion, which is the routinely used method of sperm
preparation in AMP laboratories, allowed a reduction of
about 40% in EPS-positive spermatozoa. This reduction
in EPS-positive spermatozoa was similar to that found for
the larger sperm samples subgroup, n = 36 (Table 4). The
use of the MACS-ANMB technique allowed a further
reduction of about 50% of EPS-positive spermatozoa in
the non apoptotic annexin V-negative fraction. In other
words, we saw a decrease of minus 9% EPS-positive sper-
matozoa in DGC compared to raw sperms, and a further
decrease minus 6.4% EPS-positive spermatozoa in MACS-
ANMB-DGC compared to DGC-prepared sperms (Table
4). The sensitivity and specificity of the MACS-ANMB
technique for the separation of EPS-positive spermatozoa
was evaluated by labeling the unbound annexin V-nega-
tive fraction and the bound annexin V-positive fraction
from each sperm sample with annexin V-FITC and by vis-
Table 2: Localization of PS on spermatozoa labeled by annexin V-FITC in DGC-prepared sperm
PS localization DGCprepared sperm
Noncapacitated Sperm
(n = 29) DGC-prepared sperm
Capacitated Sperm
(n = 29)
Total (%A-) + (%A+) 100 100
Annexin V- (%A-) 86.7 ± 1.8 (61–98) 83.7 ± 1.8 (55–98)
Annexin V+ (%A+) 13.3 ± 1.8 (2–39) 100 16.3 ± 1.8 (2–45)S 100
Head 14.7 ± 2.2 (0–46) 18.6 ± 2.0 (0–57)S
Head and Midpiece 11.5 ± 1.9 (0–38) 15.4 ± 1.8 (0–44)S
Midpiece 7.7 ± 1.4 (0–27) 7.8 ± 1.3 (0–22) NS
Tail 4.7 ± 1.2 (0–33) 5.1 ± 1.4 (0–33) NS
Entire spermatozoon 61.4 ± 3.6 (25–100) 53.1 ± 3.5 (18–89)S
Values are mean percentages ± SEM (minimum-maximum values).
NS = statistically not significant compared to noncapacitated sperm (paired t-test).
S = statistically significant compared to noncapacitated sperm with p < 0.05 (paired t-test)Reproductive Biology and Endocrinology 2009, 7:1 http://www.rbej.com/content/7/1/1
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ualization under a fluorescent microscope. On average,
67.8% spermatozoa were recognized as EPS-positive in
the annexin V-positive fraction and 6.7% were recognized
as EPS-positive in the annexin V-negative fraction (Table
4).
DGC combined with MACS-ANMB had an effect on the 
quality of spermatozoa in terms of MMP integrity and 
progressive motility
The mean percentage of MMP-disrupted spermatozoa in
raw sperm samples (n = 15) was 58% and this value fall
to 37% following DGC preparation and to 25% after DGC
combined with MACS-ANMB (Table 4). DGC sperm prep-
aration allowed a reduction of about 30% in MMP-dis-
rupted spermatozoa. A comparable result was obtained
for the larger subgroup with 31 sperm samples (Table 4).
The use of the MACS-ANMB technique allowed a further
reduction of about 30% in MMP-disrupted spermatozoa
in the non apoptotic annexin V-negative fraction. In other
words, we observed a decrease of minus 21% MMP-dis-
rupted spermatozoa in DGC compared to raw sperms,
and a further decrease of minus 12% MMP-disrupted
spermatozoa in MACS-ANMB compared to DGC-pre-
pared sperms (Table 4).
DGC sperm preparations greatly enriched the population
of progressive motile spermatozoa, categories 3 and 2
according to World Health Organisation [1]. In our exper-
imental conditions, the addition of the MACS-ANMB
technique to DGC preparations only slightly improved
the sperm motility. In other words, we report an increase
of plus 16% (n = 28) and plus 20% (n = 20) spermatozoa
with progressive motility in DGC compared to raw
sperms, and an increase of plus 3.5% (n = 28) and plus
6% (n = 20) spermatozoa with progressive motility in
MACS-ANMB compared to DGC-prepared sperms) (Table
4 and 5).
Positive effect of DGC combined with MACS-ANMB on 
sperm survival
Mean progressive motility of raw sperms (n = 20) was
increased by 40% by DGC preparation (69% compared to
49%) and further increased by 10% by passage through
MACS-ANMB (76% compared to 69%) (Table 5). To fur-
ther study the increased viability and motility after
removal of EPS spermatozoa from prepared sperm, we
evaluated the motility 24 h following sperm preparation
by DGC or DGC combined with MACS-ANMB (Table 5).
The results showed that sperm survival at 24 h expressed
in mean percentage of progressive motility was higher in
DGC combined with MACS-ANMB preparations than in
DGC preparations alone, with approximately 48% against
32% progressive motile spermatozoa, respectively. Sperm
survival at 24 h was thus increased by 50% by passage
through MACS-ANMB, an increase considerably more
pronounced than the 10% increase in progressive motility
observed rapidly following the passage through MACS-
ANMB (Table 5).
Sperm recovery rate after MACS-ANMB preparation
The MACS-ANMB technique in our experimental condi-
tions, including infertile sperms of either low motility
rates, poor morphology and/or low amount of spermato-
zoa (0.5 to 10 millions), allowed us to recover a mean of
76% of the quantity (million) of spermatozoa loaded on
MACS-ANMB column (Table 6). Nevertheless, the recov-
ery rate of spermatozoa expressed in percentage of sper-
matozoa charged on the MACS-ANMB column, washing
and resuspension in BM1 medium, greatly vary among
sperm, from a minimum of 36% to a maximum of 100%
recovery when compared with spermatozoa recovered at
the end of the preparation after passage through the col-
umn. There is a significant positive correlation between
the amount of spermatozoa (in million) loaded on MACS
and the MACS recovery rate (R = 0.48). The percentage of
spermatozoa collected in the MACS-ANMB-negative frac-
tion, corresponding to the non apoptotic fraction, was
higher than in the MACS-ANMB-positive fraction, corre-
sponding to the apoptotic fraction, 89% and 11%, respec-
tively (Table 6).
Localization of PS on human spermatozoa Figure 1
Localization of PS on human spermatozoa. PS are vis-
ualized by labeling spermatozoa with annexin V-FITC stain-
ing. (A) A spermatozoa as seen under bright field 
microscopy. (B-F) Representative patterns of annexin V-FITC 
binding sites: head (B), midpiece (C), head plus midpiece (D), 
tail (E), or entire spermatozoon (F) plasma membrane as 
seen under fluorescence microscopy. Magnification ×900.
A
D
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Discussion
Several studies have shown that ejaculated spermatozoa
do exhibit changes consistent with apoptosis in particular
EPS, decrease in MMP integrity, DNA fragmentation and
expression of a number of pro- and anti-apoptotic pro-
teins [73]. Unfortunately, DGC preparation, which is the
technique currently used for sperm preparations in AMP
laboratories [74], does not eliminate all spermatozoa with
apoptotic features. The present study was carried out to
quantify EPS-positive spermatozoa and localize PS on
spermatozoa in a population of infertile patients attend-
ing our in vitro Fertilization laboratory and to measure the
impact of removing these EPS-positive spermatozoa by
MACS-ANMB on sperm quality.
We determined in raw and DGC-prepared sperm from
infertile patients the proportion of spermatozoa with
compromised survival and fertility potential. In raw
sperm, a mean of 20% (min 5%–max 68%) are annexin
V-positive (Table 4). Following DGC, about 30% of the
spermatozoa are still in late apoptotic or necrotic state and
about 14% are annexin V-positive (Table 1).
The moderate increase in annexin-V-positive spermatozoa
observed following incubation in capacitating conditions
(involving only the A+/H+ subpopulation, Table 1) might
be due to the in vitro incubation. Indeed, the number of
live sperm drops quickly over time in samples from
patients with poor semen quality. We cannot rule out the
possibility that the A+/H- is a quick and transitory sub-
population being converted in the A+/H+ subpopulation
[49], as also suggested by Sion et al. [43]. Kotwicka et al.
[12] detected an increase from 15% to 35% annexin V-
positive spermatozoa following incubation in capacitat-
ing medium. Martin et al. [54] showed that EPS is mainly
related to the acrosome reaction because calcium iono-
Diagram of overall experimental design showing the different steps performed in our study Figure 2
Diagram of overall experimental design showing the different steps performed in our study. Number of semen 
samples analysed for each experimental set: total sperm samples: 44, DGC-EPS: 36, DGC combined with MACS-EPS: 21, 
DGC-MMP: 31, DGC combined with MACS-MMP: 15, DGC combined with MACS-Motility: 28, DGC combined with MACS-
Survival at 24 h: 20 (see also Table 4).
Density Gradient Centrifugation (DGC) 
Sperm samples 
Magnetic-Activated Cell Sorting 
(MACS-ANMB) 
Non apoptotic fraction 
Annexin V-negative
Apoptotic fraction 
Annexin V-positive
Sperm parameters : Concentration, Motility 
Externalized phosphatidylserine (EPS) : Annexin V-FITC 
Mitochondrial membrane potential (MMP) : Rhodamine 123 
Table 3: Sperm parameters of patients
Raw sperm
Patients
Volume Concentration
(106/ml)
Total Count
(106/ejaculate)
Motility
(%progressive)
Morphology
(%normal forms)
n = 44 3.7 ± 0.2 75.7 ± 7.0 259.1 ± 23.3 49.1 ± 1.9 7.8 ± 0.9
Values are means ± SEMReproductive Biology and Endocrinology 2009, 7:1 http://www.rbej.com/content/7/1/1
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phore A23187 induced a significant increase in the pro-
portion of living EPS-positive spermatozoa from 7 to
48%.
Results from the literature are still controversial. Some
authors reported that EPS was related to sperm capacita-
tion process due to a bicarbonate-activated outward trans-
location of PS [11,15,54]. In contrast, other reports found
correlations between EPS and apoptotic events such as
DNA fragmentation, caspases activities and/or loss of
MMP integrity [6,7,44-47,49,50,52,53]. Taken together,
EPS spermatozoa could be survivors of a testis abortive
apoptotic process or the result of oxidative stresses initi-
ated during the transit or storage in the male genital tract
or be linked to a physiological event in the post-ejacula-
tion period. We could also speculate that spermatozoa
might enter an apoptotic-like pathway, giving a physio-
logical role to EPS during capacitation/acrosome reaction,
for the acquisition of fertilizing ability, in a natural mech-
anistic economy. Such mechanism would be dependent
on a correct schedule for successful fertilization [75], or
otherwise it would be converted in the apoptotic signal for
elimination by phagocytic cells. Indeed, it is known that
many boar spermatozoa are phagocytized after insemina-
tion, thus reducing the risk of eliciting a harmful immune
reaction that may interfere with fertilization or embryos
implantation [76]. Altogether, regardless of whether EPS
represent, an apoptotic marker or a capacitated/acrosome
reacted marker, EPS-positive spermatozoa in fresh ejacu-
lates are potentially harmful in AMP being in apoptosis or
off schedule for fertilization, respectively.
Concerning the localization of PS on human spermatozoa
(Figure 1 and Table 2), we found several categories of
annexin V-positive spermatozoa. Our results are similar to
those of Shen et al. [49] who also reported annexin V-
labeling around head, midpiece and certain parts of the
tail. Following incubation in capacitating conditions we
found an increase in both head and head plus midpiece
categories. Kotwicka et al. [12] also found a change in the
localization of PS during capacitation, firstly mainly in the
midpiece and then in the acrosomal region of the head. de
Vries et al. [15] reported that PS in living spermatozoa was
restricted to the apical area of the head plasma membrane,
whereas deteriorated spermatozoa presented PS at the
midpiece. The various PS localizations on spermatozoa
could thus be interpreted as different stages of the
dynamic physiological process of capacitation/acrosome
reaction or apoptosis versus necrosis status.
Numerous reports linked fertilization failures to apop-
totic markers [8,45,77,78]. Infertile patients have higher
rates of spermatozoa with EPS, activated caspases and/or
loss of MMP integrity [7,45,50]. Therefore MACS-ANMB,
which eliminate EPS-positive spermatozoa, is adapted to
human sperm in the context of seeking new techniques
with better criteria of selection for sperm preparations in
AMP [39]. Our study on sperm from infertile patients
shows that DGC combined with MACS-ANMB is: 1)
applicable to low amount, 43% of sperm tested with less
than 5 million spermatozoa, and/or bad quality sperma-
tozoa, 2) efficient in removing EPS spermatozoa and, 3)
efficient in enhancing the quality of spermatozoa in term
of MMP integrity, progressive motility and most impor-
Table 4: EPS, MMP and progressive motility in raw sperm, in DGC and in DGC combined with MACS-ANMB prepared sperm
Criteria, subgroups Raw sperm DGC sperm DGC+MACS sperm
Non Apoptotic Fraction
DGC+MACS sperm
Apoptotic Fraction
EPS (%A+), n = 36 20.0 ± 2.3 (5–68) 11.8 ± 1.4 (1–32) - -
EPS (%A+), n = 21 22.1 ± 3.4 (5–68) 13.1 ± 2.0 (1–32) 6.7 ± 1.2 (1–22) 67.8 ± 4.2 (25–94)
MMP disruption (%MMP-), n = 31 61.7 ± 3.2 (30–95) 44.2 ± 3.7 (16–86) - ND
MMP disruption (%MMP-), n = 15 57.9 ± 4.5 (30–91) 37.0 ± 5.0 (16–86) 24.7 ± 5.6 (6–82) ND
Motility, n = 28 (%progressive) 48.4 ± 2.4 (17–71) 64.4 ± 3.8 (22–91) 67.9 ± 5.4 (0–97) 8.0 ± 2.6 (0–53)
Values are means ± SEM (minimum-maximum values).
All values are statistically significantly different when comparing DGC+MACS, DGC, raw samples (p < 0.05, paired t-test) except for the value of 
motility 67.9 compared to 64.4.
Table 5: Sperm survival at 24 h in DGC and DGC plus MACS-ANMB preparations
n = 20 Raw
sperm
DGC sperm DGC+MACS sperm Non 
Apoptotic Fraction
DGC sperm Survival at 24 h DGC+MACS sperm Non 
Apoptotic Fraction Survival at 
24 h
Motility (%progressive) 48.9 ± 3.0
(17–71)
69.3 ± 4.2
(22–91)
75.6 ± 5.2
(20–97)
32.4 ± 6.1
(0–78)
47.5 ± 7.0
(0–88)
Values are means ± SEM (minimum-maximum values).
All values are statistically significantly different (p < 0.05, paired t-test)Reproductive Biology and Endocrinology 2009, 7:1 http://www.rbej.com/content/7/1/1
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tantly in terms of sperm survival. In our serie of experi-
ments the sensitivity and specificity of MACS-ANMB
technique for the separation of EPS-positive spermatozoa
(Table 6) are very similar to that reported by Paasch et al.
[50,79], except that we labeled spermatozoa by annexin
V-FITC and observed them by fluorescence microscope
rather than labeling with FITC-conjugated anti-annexin V
antibodies followed by FACS analysis. Indeed, in the
apoptotic fraction a mean of 67.8% (n = 17 infertile
patients, Table 4) of spermatozoa were recognized as EPS-
positive compared to 72.2% (n = 30 with15 infertile and
15 fertile donors, [79] and in the non apoptotic fraction a
mean of 6.7% (n = 21 infertile patients, Table 4) were rec-
ognized as EPS-positive compared to 5.2% [79]. Thus,
DGC combined with MACS-ANMB was efficient in
removing EPS-positive spermatozoa. MACS-ANMB allows
a further decrease of 50% in EPS spermatozoa, with a
mean of less than 7% EPS-positive spermatozoa in the
non-apoptotic fraction.
We show that combining MACS-ANMB with DGC for
sperm preparations had a positive effect on spermatozoa
MMP integrity (Table 4). MACS-ANMB allowed a further
reduction of 30% in MMP-disrupted spermatozoa, with a
mean of 75% of spermatozoa with MPP integrity, com-
pared to DGC alone. Removal of MMP-disrupted sperma-
tozoa is of interest in AMP, since the functionality of
mitochondria differentiates human spermatozoa with
high and low fertilizing ability [80]. MACS-ANMB com-
bined with DGC also enhanced spermatozoa progressive
motility (76% compared to 69% in DGC, +7%) and most
outstandingly sperm survival at 24 h (48% compared to
32% in DGC, +16%), however the data showed a great
individual variability among sperm from minus 35% to
plus 75% (Table 5). In a similar way, the use of the MACS-
ANMB technique prior to sperm cryopreservation allowed
a significantly higher cryosurvival rate expressed in motil-
ity following cryopreservation-thawing [51,70,81]. The
better sperm survival at 24 h in DGC plus MACS-ANMB
treated sperm suggested that in addition to a purely quan-
titative decrease of the percentage of EPS apoptotic sper-
matozoa, their removal might protect healthy
spermatozoa from reactive oxygen species production.
Indeed, excessive reactive oxygen species, produced either
by the presence of immature and abnormal spermatozoa
or seminal leukocytes result in altered semen parameters,
including viability, motility and morphology [82-90].
We have also undertaken the evaluation of the extent of
spermatozoa loss using MACS-ANMB technique. The
average number of lost spermatozoa was 24% (n = 28)
which is considerably greater than the 15% obtained by
Said et al. [69] following DGC plus MACS. This discrep-
ancy may be explained by the use of low amount of sper-
matozoa from infertile sperm, which reflect the clinical
situation in assisted medical procreation.
Conclusion
In conclusion, our results demonstrate in infertile sperm
that MACS-ANMB is a simple, fast, low cost cell sorting
system that can be easily adapted in AMP Laboratories to
enhance classical sperm parameters and lower sperm
apoptotic markers. These results confirm and expand the
data from the groups of Cleveland and Leipzig using nor-
mal sperm [39,65-70,81,91,92]. Additionnally, these
authors reported that MACS-ANMB technique yielded a
sperm population with higher normal morphology,
reduced caspase-3 activation and DNA fragmentation.
The cryosurvival rates and sperm fertilization potential
were also improved as measured by higher oocyte pene-
tration capacity in a zona free hamster sperm penetration
assay [69,70,91]. Taken together, sperm preparations
combining DGC with MACS-ANMB, should significantly
enhance the outcome of AMP in terms of fertilization,
embryo quality, pregnancies and birth rates. Even though,
Varum et al.[93] suggested that elimination of defective
spermatozoa using the surface marker annexin V seems
unwarranted because annexin V and DNA nicks did not
correlated with ubiquitin labeling. Further investigations
need to be conducted to assess safety of the magnetic field
and the eventual residual microbeads on spermatozoa
[50,70].
Implementation of MACS is very promising for the future
of ART because MACS has many potential applications in
diverse male infertilities due to the possibility of selecting
the antibody of the ligand protein used for sperm selec-
tion [70]. Very recently, a newly developed solid phase
molecular filtration system combining classical glass wool
filtration with PS-binding properties of annexin V has
Table 6: Sperm recovery rate
Sperm
n = 28
Loaded on MACS Recovered from
both fractions
Recovered from the
Non Apoptotic Fraction
Recovered from the
Apoptotic Fraction
Million 6.74 ± 0.63 (0.5–10) 5.30 ± 0.62 (0.28–10) 4.87 ± 0.1 (0.24–9.95) 0.43 ± 0.1 (0.01–1.5)
% 100% 75.8 ± 3.7*
% 100% 89.2 ± 2.2* 10.8 ± 2.2*
Values are means ± SEM in million spermatozoa (minimum-maximum values)Reproductive Biology and Endocrinology 2009, 7:1 http://www.rbej.com/content/7/1/1
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been proven to enrich spermatozoa free of apoptosis
markers to the same extent as MACS but without the
potential inconvenient of an accidental transmission of
supermagnetic microbeads into oocytes [94]. Overall, PS
might become the prognostic marker of sperm fertility
potential easy to use for sorting spermatozoa in ART. In
consequence, discarding EPS spermatozoa may optimize
AMP outcomes.
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